Tracking TrkB agonists

TrkB agonists aren't what they seem

It turns out that neurotrophic TrkB agonists used in many publications aren't TrkB agonists after all, according to a recent Science Signaling paper from Columbia University and the Broad Institute of MIT and Harvard. The publication reinforces concerns raised in a 2014 paper from the CHDI Foundation Inc. and is an illustration of why high-profile journals and funding agencies should support "negative" data studies at a time when translational research is grappling

Read the full 721 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers